BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  Can-Fite BioPharma: Seikagaku Corporation, the Exclusive Licensee of CF101 in Japan, Is to Commence Phase I Clinical Trial in Japan With CF101 for the Treatment of Rheumatoid Arthritis

  August 18, 2008

   · 

  1 min read
• Business

  Mallinckrodt Baker, Inc. and Rubicon Research Sign Agreement for Performance Excipient Development

  August 18, 2008

   · 

  1 min read
• Drug Development

  Dyax Corp. HAE Drug Meets Main Goal; Shares Jump

  August 18, 2008

   · 

  7 min read
• Drug Development

  Albany Molecular Research, Inc. Initiates Phase I Study of Proprietary Oncology Drug Candidate

  August 18, 2008

   · 

  1 min read
• Genetown

  Novelos Therapeutics, Inc. Closes $3 Million Private Placement

  August 18, 2008

   · 

  1 min read
• Business

  Medegen Inc. Grows Product Distribution Via Co-Marketing Agreement with C. R. Bard, Inc.

  August 18, 2008

   · 

  1 min read
• Technology Vision Group Release: BioPartnering Europe 2008 Conference

  August 18, 2008

   · 

  1 min read
• Pharm Country

  Pluristem Therapeutics to Present at the Noble Financial Equity Conference

  August 18, 2008

   · 

  1 min read
• Drug Development

  Repros Therapeutics Inc. Provides Update for US Phase II Endometriosis Study and Completion of QT Interval Dose Selection Screen

  August 18, 2008

   · 

  1 min read
• Pharm Country

  American Bio Medica Corporation Completes Series A Debenture Offering

  August 18, 2008

   · 

  1 min read